Breakthrough Insights from Singapore's Gastric Cancer Research Consortium
The latest research from Duke-NUS Medical School and the National University Health System (NUHS) has illuminated the intricate interplay of factors driving stomach cancer, also known as gastric cancer. Published in the prestigious journal Cancer Discovery, the study analyzed over 1,500 samples of intestinal metaplasia (IM)—a precancerous condition where stomach lining cells transform to resemble those in the intestine—collected from patients across six countries, including Singapore, Hong Kong, Japan, South Korea, Taiwan, and the United States.
Led by Professor Patrick Tan, Dean of Duke-NUS Medical School, and Professor Yeoh Khay Guan, Chief Executive of NUHS and Kishore Mahbubani Professor at the National University of Singapore (NUS) Yong Loo Lin School of Medicine, the work under the Singapore Gastric Cancer Consortium (SGCC) reveals how age-related changes, smoking, oral bacteria infiltration, and specific genetic mutations converge to amplify risk by up to sixfold. This multidisciplinary effort, involving NUS Medicine, Nanyang Technological University's Lee Kong Chian School of Medicine (LKCMedicine), A*STAR's Genome Institute of Singapore, and international partners, underscores Singapore's position as a hub for cutting-edge biomedical research.
Gastric cancer remains a major global health challenge, ranking as the fifth most common cancer and the fourth leading cause of cancer deaths worldwide, with approximately 769,000 fatalities in 2020 alone. In Singapore, it claims between 300 and 500 lives annually, placing it among the top 10 cancer-related killers, particularly as the population ages rapidly.
Unpacking Intestinal Metaplasia: The Silent Precursor to Gastric Cancer
Intestinal metaplasia (IM) represents a critical step in the multistage progression of gastric cancer. Normally, the stomach's epithelial cells are specialized for acid production and digestion, but chronic irritation—often from infections, diet, or inflammation—triggers a cellular adaptation where these cells mimic intestinal ones. This metaplastic change is reversible in early stages but can advance to dysplasia and invasive cancer if unchecked.
The SGCC's longitudinal study, initiated in 2007, tracked over 1,100 patients with chronic gastritis or gastroesophageal reflux disease who exhibited IM. Advanced genomic sequencing identified 47 significantly mutated genes in IM tissues, with profound implications for early detection. Patients with IM face roughly a six times higher risk of progressing to gastric cancer compared to the general population, making it a pivotal checkpoint for intervention.
In Singapore's context, where gastric cancer incidence stands at about 18.1 cases per 100,000 person-years, understanding IM's heterogeneity is vital. Not all IM cases progress equally; genetic profiling now allows differentiation between low- and high-risk profiles, optimizing surveillance efforts.
The Role of Ageing and Clonal Hematopoiesis in Cancer Susceptibility
Ageing emerges as a foundational risk amplifier through clonal hematopoiesis (CH), a phenomenon where mutations accumulate in hematopoietic stem cells in the bone marrow. CH, prevalent in up to 10-20% of individuals over 70, leads to expanded clones of mutated blood cells, impairing immune surveillance and promoting inflammation.
The study found elevated CH in gastric cancer patients' blood samples, particularly those with IM. This age-related genetic drift weakens the body's ability to combat precancerous changes in the stomach. In Singapore's greying society—with one in four residents projected to be 65+ by 2030—CH screening could become a routine biomarker for high-risk elderly patients.
Professor Patrick Tan notes, "Gastric cancer builds over many years through ageing, genetic changes, immune shifts, and bacteria. These insights support Singapore's healthy longevity goals."
Smoking's Devastating Impact: The SBS17 Signature Exposed
Tobacco smoking accelerates gastric carcinogenesis via the SBS17 mutational signature, a pattern of DNA damage tied to oxidative stress from aberrant nucleotide metabolism. Absent in healthy gastric tissue, SBS17 was prevalent in IM samples and worsened by smoking exposure, which activates nicotinic receptors and heightens cellular damage.
- Smokers with IM showed higher SBS17 loads, correlating with faster progression.
- Oxidative stress disrupts DNA repair, paving the way for oncogenic mutations.
- Quitting smoking could mitigate this signature, offering a modifiable risk reducer.
Public health campaigns in Singapore, emphasizing smoke-free environments, gain further urgency from these findings, potentially averting hundreds of cases annually.
Oral Bacteria Invasion: Streptococcus and Chronic Inflammation
Beyond the well-known Helicobacter pylori, oral bacteria such as Streptococcus species—common in periodontal disease—were detected at elevated levels in the stomachs of CH-positive patients. This "dual hit" of immune compromise and microbial overgrowth fosters persistent inflammation, eroding the gastric mucosa.
Mechanistically, compromised blood cells fail to clear these invaders, allowing biofilms to form and release pro-inflammatory cytokines. Good oral hygiene, regular dental check-ups, and possibly targeted antimicrobials emerge as preventive strategies. Professor Yeoh Khay Guan highlights, "Eliminating specific bacteria could open new prevention avenues."
Duke-NUS Media ReleaseGenetic Mutations Spotlight: ARID1A as a Key Driver
Among the 47 mutated genes, ARID1A—AT-rich interactive domain-containing protein 1A, a tumor suppressor involved in chromatin remodeling—stood out. Lost in 17-27% of gastric cancers, ARID1A deficiency disables growth controls, propelling IM to malignancy.
- ARID1A-mutated IM predicts poorer prognosis and higher progression rates.
- Combined with CH, oral bacteria, and smoking, risk escalates synergistically.
- Genomic testing for ARID1A could stratify patients for intensive monitoring.
This genetic insight fuels precision medicine, with Singapore's advanced genomics infrastructure at A*STAR and universities positioning it as a leader.
Singapore's Battle Against Gastric Cancer: Epidemiology and Public Health Response
In Singapore, gastric cancer disproportionately affects males and those over 50, with Chinese ethnicity showing higher incidence due to dietary and genetic factors. The National Cancer Centre Singapore (NCIS) reports it as the 4th leading cancer death cause in men. SGCC's efforts, backed by the National Research Foundation, integrate research with clinical care.
Screening programs target high-risk groups, including H. pylori carriers, but this study expands criteria to include CH and oral microbiomes. Internal efforts like the Health Promotion Board's anti-smoking initiatives complement these advances.
Therapeutic Horizons: Pyrvinium and Beyond
A promising discovery: pyrvinium, an FDA-approved antiparasitic for pinworms, potently inhibits IM cell proliferation by targeting Wnt signaling pathways hyperactive in precancerous tissues. Preclinical mouse and organoid models confirmed its efficacy in reversing metaplasia.
SGCC plans early-phase trials within 1-2 years, potentially repurposing this cheap drug for chemoprevention. Other avenues include microbiome modulation via probiotics or antibiotics, and CH-modulating therapies from hematology.
Full Study in Cancer DiscoveryImplications for Research Careers in Singapore's Higher Education
This landmark study exemplifies the collaborative prowess of Singapore's higher education institutions. Duke-NUS, a partnership with Duke University, offers MD-PhD programs fostering clinician-scientists. NUS and NTU provide robust platforms for genomics and oncology research.
Aspiring researchers can explore opportunities in cancer genomics, with demand for postdocs and faculty in precision medicine. For career guidance, check how to craft a winning academic CV or browse research jobs and postdoc positions in Singapore via AcademicJobs.sg.
Photo by Galen Crout on Unsplash
Future Outlook: Precision Prevention and Global Impact
Integrating multi-omics—genomics, microbiomics, epigenomics—will refine risk models, enabling personalized screening. Singapore's SGCC model could inspire consortia worldwide, reducing gastric cancer's toll.
Actionable steps: Quit smoking, maintain oral health, undergo regular endoscopies if at risk, and stay informed via trusted sources. For professionals, engaging in such research advances both science and careers. Explore higher ed jobs, rate your professors, or career advice to join this vital field.